KR101715159B1 - 미코플라스마 갈리셉티쿰 제형 - Google Patents

미코플라스마 갈리셉티쿰 제형 Download PDF

Info

Publication number
KR101715159B1
KR101715159B1 KR1020117019444A KR20117019444A KR101715159B1 KR 101715159 B1 KR101715159 B1 KR 101715159B1 KR 1020117019444 A KR1020117019444 A KR 1020117019444A KR 20117019444 A KR20117019444 A KR 20117019444A KR 101715159 B1 KR101715159 B1 KR 101715159B1
Authority
KR
South Korea
Prior art keywords
mycoplasma
strain
gallericepticum
deposited
galliscepticum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020117019444A
Other languages
English (en)
Korean (ko)
Other versions
KR20110123748A (ko
Inventor
스탠리 에이치. 클레벤
나올라 엠. 퍼거슨
Original Assignee
유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드 filed Critical 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드
Publication of KR20110123748A publication Critical patent/KR20110123748A/ko
Application granted granted Critical
Publication of KR101715159B1 publication Critical patent/KR101715159B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020117019444A 2009-01-22 2010-01-22 미코플라스마 갈리셉티쿰 제형 Active KR101715159B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14647209P 2009-01-22 2009-01-22
US61/146,472 2009-01-22
PCT/US2010/021749 WO2010085611A2 (en) 2009-01-22 2010-01-22 Mycoplasma gallisepticum formulation

Publications (2)

Publication Number Publication Date
KR20110123748A KR20110123748A (ko) 2011-11-15
KR101715159B1 true KR101715159B1 (ko) 2017-03-10

Family

ID=42356391

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117019444A Active KR101715159B1 (ko) 2009-01-22 2010-01-22 미코플라스마 갈리셉티쿰 제형

Country Status (9)

Country Link
US (1) US8668912B2 (https=)
EP (1) EP2389433B1 (https=)
JP (1) JP5642710B2 (https=)
KR (1) KR101715159B1 (https=)
CN (1) CN102292432B (https=)
BR (1) BRPI1006947B1 (https=)
CA (1) CA2749213C (https=)
MX (1) MX2011007732A (https=)
WO (1) WO2010085611A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2943219T4 (pl) * 2012-09-10 2022-08-22 Susan Szathmary Szczepionka do zapobiegania zakażeniu mykoplazmalnemu u ptactwa wodnego
CN106967829A (zh) * 2017-05-18 2017-07-21 隋兆峰 一种鉴别mg 6/85株的套式pcr检测方法
CN110218808B (zh) * 2019-06-28 2021-07-13 华中农业大学 滑液囊支原体和鸡毒支原体的四重pcr检测试剂盒
CN119816588A (zh) * 2022-04-06 2025-04-11 乔治亚大学研究基金公司 鸡毒支原体活疫苗
US20260014240A1 (en) * 2022-07-20 2026-01-15 University Of Connecticut Rationally designed mycoplasma gallisepticum subunit vaccine
CN118078972B (zh) * 2024-03-07 2024-10-22 佛山大学 一种鹅源鸡毒支原体灭活疫苗及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070178115A1 (en) 2005-08-15 2007-08-02 Tang De-Chu C Immunization of avians by administration of non-replicating vectored vaccines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196514A (en) 1990-03-06 1993-03-23 The University Of Georgia Research Foundation, Inc. Method of detecting mycoplasma infection in poultry and compositions therefor
WO1993001276A1 (en) 1991-07-12 1993-01-21 Smithkline Beecham Corporation Continuous cell line and vaccine against avian coccidia
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
US7785822B2 (en) 2002-08-27 2010-08-31 University Of Georgia Research Foundation, Inc. Assays for the detection of biliverdin in birds and reptiles

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070178115A1 (en) 2005-08-15 2007-08-02 Tang De-Chu C Immunization of avians by administration of non-replicating vectored vaccines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
VETERINARY MICROBIOLOGY. 2008, vol. 129, no. 1-2, PAGE 179-187.*
Ziv Raviv. THE ROLE OF MYCOPLASMA SYNOVIAE IN COMMERCIAL LAYER E.COLI PERITONITIS SYNDROME AND MYCOPLASMA GALLISEPTICUM INTRASPECIFIC DIFFERENTIATION METHODS, A Dissertation, 2007.05.

Also Published As

Publication number Publication date
HK1161289A1 (zh) 2012-08-24
BRPI1006947A2 (pt) 2016-10-04
CA2749213A1 (en) 2010-07-29
BRPI1006947B1 (pt) 2020-02-04
WO2010085611A2 (en) 2010-07-29
CA2749213C (en) 2017-08-15
KR20110123748A (ko) 2011-11-15
CN102292432B (zh) 2013-05-22
US8668912B2 (en) 2014-03-11
EP2389433A2 (en) 2011-11-30
WO2010085611A3 (en) 2010-11-25
CN102292432A (zh) 2011-12-21
MX2011007732A (es) 2011-11-04
EP2389433B1 (en) 2015-11-25
JP5642710B2 (ja) 2014-12-17
US20120021005A1 (en) 2012-01-26
JP2012515552A (ja) 2012-07-12
EP2389433A4 (en) 2012-10-17

Similar Documents

Publication Publication Date Title
US8277814B2 (en) Avian Astrovirus
CN106947746B (zh) 鸡传染性支气管炎致弱疫苗株ldl-t株及其应用
KR101715159B1 (ko) 미코플라스마 갈리셉티쿰 제형
KR101656301B1 (ko) 마이코플라즈마 보비스 백신
EP4504902A1 (en) Live mycoplasma gallisepticum vaccines
KR20120016282A (ko) 마이코플라스마　하이오뉴모니에의 온도 감수성 백신 균주 및 그의 용도
CN109207436B (zh) 一株i群4型禽腺病毒毒株及其应用
Avellaneda et al. In vivo evaluation of the pathogenicity of field isolates of infectious bronchitis virus
CN102952785A (zh) 猪伪狂犬病毒、疫苗组合物及其应用
MXPA05000467A (es) Formulacion de micoplasma gallisepticum.
CN108251338A (zh) 猪鼻支原体强毒株及其应用
US9764017B2 (en) Potomac horse fever isolates
HK1161289B (en) Mycoplasma gallisepticum formulation
Liu et al. A newly developed temperature-sensitive Mycoplasma synoviae live attenuated strain prevents pathological lesions of the respiratory and reproductive tracts in chickens caused by a wild-type M. synoviae strain
US20030149255A1 (en) Bird diagnostics and treatments
KR101560337B1 (ko) 신규한 조류메타뉴모바이러스 및 그 백신
CN117736934A (zh) 一种鸡滑液囊支原体及其在制备灭活疫苗中的应用
CN118956778A (zh) Gi-19型鸡传染性支气管炎病毒弱毒疫苗株及其应用
Mathengtheng Molecular characterization of Mycoplasma gallisepticum strains from South African poultry
MATHEWS ASSESSMENT OF IMMUNOGENIC POTENCY OF INACTIVATED VACCINE AGAINST RIEMERELLOSIS IN BREEDER DUCKS
US20080057078A1 (en) Chicken Anemia Virus Vaccine from Cell Line

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20200303

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 10